Delivery Order SPE2DB24D3015-SPE2DB25FFZYU
- Not listed
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of EXJADE 500 MG TABLET 30S, a pharmaceutical product, with a ceiling value of $16,027.08 and a period of performance through July 16, 2025. The contract is a firm fixed-price delivery order, which is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant...
- This is a delivery order under contract SPE2DB20D1100 awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $5,127.33 firm fixed-price contract is for the supply of EXJADE 250 MG TABLET 30S, a prescription medication. There is no set-aside designation for this award. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a comprehensive range of...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,451.24 Firm Fixed Price Delivery Order is for the supply of EXJADE 500 MG TABLET 30S, a pharmaceutical product, with a period of performance through November 16, 2023. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of EXJADE 500 MG TABLET 30S, a pharmaceutical product, with a firm fixed price and a ceiling value of $16,027.08. The contract has an ultimate completion date of June 12, 2025. Amerisourcebergen Drug Corp is a for-profit organization registered in SAM.gov since 2002 and serves as a...
- The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical supplier, to provide EXJADE 125 MG TABLET 30S for $6,761.12. This order is associated with Amerisourcebergen's $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which enables the DLA to efficiently procure a comprehensive range of pharmaceutical products and medical supplies for the Department...
- This federal contract award is for the delivery of EXJADE 250 MG TABLET 30S, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The $5,034.60 firm-fixed-price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on July 13, 2023, with a completion date of August 3, 2023. The contract is a delivery order placed under Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $16,027.08 for Exjade 500 mg tablets (30-count units) on August 5, 2025, with an ultimate completion date of August 26, 2025. This firm fixed-price contract, which is not set-aside, represents a routine pharmaceutical supply requirement fulfilled by the prime contractor at its Conshohocken, Pennsylvania facility. The award is issued as a child contract under AmerisourceBergen's larger Indefinite...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,034.60 firm-fixed-price delivery order is for the supply of Exjade 250 mg tablets. The award is not designated as a set-aside contract. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which does business as Amerisourcebergen. Through its extensive distribution capabilities,...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of JADENU 360 MG TABLET 30S, a pharmaceutical product, with a ceiling value of $11,586.33 and a completion date of May 20, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $18,625.87 fixed-price delivery order is for the supply of JADENU 360 MG TABLET 30S, a pharmaceutical product, with a performance period through March 26, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
- SPE2DB24D3015Indefinite Delivery Contract
- SPE2DB24D3015-SPE2DB25FFZYUDelivery Order
This is a delivery order federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of EXJADE 500 MG TABLET 30S, with a firm fixed price and a ceiling value of $4,006.76. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This delivery order is part of the company's broader role as a critical vendor supporting federal medical procurement needs, particularly for military and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.0k | 6/30/25 |